Well Lead Medical Co., Ltd. (SHA:603309)
China flag China · Delayed Price · Currency is CNY
10.67
+0.07 (0.66%)
Oct 28, 2026, 11:30 AM CST

Well Lead Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3376.33219.39192.49166.57106.09
Depreciation & Amortization
83.6485.8674.1372.6265.5257.74
Other Amortization
11.659.434.384.322.611.62
Loss (Gain) From Sale of Assets
-0.04-0.04-0.43-0.09-0.04-0
Asset Writedown & Restructuring Costs
147.36147.361.340.467.570.56
Loss (Gain) From Sale of Investments
-3.27-3.27-7.31-8.61-5.994.84
Provision & Write-off of Bad Debts
2.042.040.210.79-1.40.83
Other Operating Activities
157.1941.4527.6530.527.7821.9
Change in Accounts Receivable
-10.11-10.1114.46-74.0459.98-20.32
Change in Inventory
-30.03-30.03-34.848.28-5.21-36.94
Change in Accounts Payable
10.4410.445.74-6.7552.750.48
Change in Other Net Operating Assets
---4.232.59213.22
Operating Cash Flow
402.67330.26306.26222.51391.13187.28
Operating Cash Flow Growth
16.22%7.83%37.64%-43.11%108.84%-18.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-168.2-206.15-315.73-357.89-181.38-109.28
Sale of Property, Plant & Equipment
0.080.321.930.340.082.94
Cash Acquisitions
------33.44
Investment in Securities
-78.74-46.5350.8915.19-388.31-17.16
Other Investing Activities
3.432.797.2617.919.670.6
Investing Cash Flow
-243.44-249.57-255.65-324.45-559.93-156.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-208.88415.91338.44177.1134.9
Long-Term Debt Repaid
--139.7-325.3-215.93-169.55-75.27
Lease Payments
-14.96-14.96-8.32-10.23-9.86-5.27
Total Debt Repaid
-208.64-139.7-325.3-215.93-169.55-75.27
Net Debt Issued (Repaid)
-21.6469.1890.62122.517.5659.63
Issuance of Common Stock
----0.69417.66
Repurchase of Common Stock
-6.99-6.99-1.97-1.06-1.36-
Common Dividends Paid
-157.15-159.2-155.6-106.84-45.49-58.56
Other Financing Activities
3.44-29.35-0.75-2.95-8.3-4.86
Financing Cash Flow
-182.33-126.35-67.7111.66-46.91413.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-5.58-2.811.871.712.58-2.1
Net Cash Flow
-28.68-48.48-15.23-88.57-213.14442.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
234.47124.11-9.47-135.38209.7578
Free Cash Flow Growth
136.86%---168.90%-42.63%
Free Cash Flow Margin
14.14%7.61%-0.63%-9.75%15.38%6.97%
Free Cash Flow Per Share
0.810.42-0.03-0.460.720.30
Levered Free Cash Flow
106.5846-63.87-230.71151.5358.19
Unlevered Free Cash Flow
111.1357.37-56.17-225.01156.4563.5
Free Cash Flow After Leases
219.5109.15-17.79-145.6199.8972.73

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
65.6246.8219.1343.9251.4145.9
Change in Working Capital
-28.9-28.9-13.1-69.95128.49-6.31